Literature DB >> 18085123

Dependence syndrome and intoxication delirium associated with zolpidem.

Pratap Sharan1, Rahul Bharadwaj, Sandeep Grover, Susanta K Padhy, Vineet Kumar, Jaspreet Singh.   

Abstract

The use of zolpidem by general practitioners and specialists alike has increased. Earlier, it was considered safe by physicians, i.e. devoid of dependence potential and the risk of serious adverse events. We report 5 patients seen over a 36-month period at the Post Graduate Institute of Medical Education and Research, which highlight the need for caution in the use of this drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085123

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  6 in total

1.  Pharmacoepidemiological characterisation of zolpidem and zopiclone usage.

Authors:  Caroline Victorri-Vigneau; F Feuillet; L Wainstein; M Grall-Bronnec; J Pivette; A Chaslerie; V Sébille; P Jolliet
Journal:  Eur J Clin Pharmacol       Date:  2013-07-23       Impact factor: 2.953

Review 2.  Fighting insomnia and battling lethargy: the yin and yang of palliative care.

Authors:  Mellar P Davis; Harold Goforth
Journal:  Curr Oncol Rep       Date:  2014-04       Impact factor: 5.075

3.  Severe Chronic Abuse of Zolpidem in Refractory Insomnia.

Authors:  Giacomo Chiaro; Anna Castelnovo; Giovanni Bianco; Piermario Maffei; Mauro Manconi
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

4.  Indian research on acute organic brain syndrome: Delirium.

Authors:  Charles Pinto
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

5.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

6.  A case of Zolpidem dependence successfully detoxified with gabapentin.

Authors:  Wenona H Fernandes; Yvonne Da Silva Pereira; Salvador O' Tereza
Journal:  Indian J Psychiatry       Date:  2013-07       Impact factor: 1.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.